Health Products

Simplexa Covid-19 Direct Assay

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices
Product: Simplexa Covid-19 Direct Assay
Issue: Medical devices - Manufacturing defect
What to do: Contact the manufacturer if you require additional information.
Audience: General public, Health professionals, Hospitals
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected ProductsLot or Serial NumberModel or catalog number
Simplexa Covid-19 Direct Assay12501N, 11269N, 13183N, 12348N, 11784NMOL4150

Issue

It was recently internally identified that five (5) lots of Simplexatm COVID-19 direct (Ref MOL4150) were shipped to Canada that had been manufactured with the recombinant hot start polymerase produced by Diasorin S.P.A. instead of the enzyme from an external supplier. While the validation for the material made by Diasorin S.P.A. had been successfully completed, the change had not yet been approved by Health Canada for use in products shipped to Canada patient results are not impacted by this compliance related issue.

Recall start date: Jan 7, 2022

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime